HRA PHARMA DEVELOPMENT
Business purpose.
La commercialisation et l'exploitation de tous produits pharmaceutique, para pharmaceutique, médicaux, para médicaux, vétérinaires, para vétérinaires, chimiques et plus généralement de tous produits concernant ou pouvant concerner la société. La prestation de services en matière de pharmacovigilance.
HRA PHARMA DEVELOPMENT is a company registered under SIREN number 433432176, with its registered office in CHATILLON. Its main activity falls under the sector: Wholesale trade, except of motor vehicles and motorcycles. It is administratively ceased. It has 3 establishments. 1 serving director is recorded in the national business register. Its reported revenue for the financial year ended in 2018 is 0 euros.
Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.
Identity
- Legal form
- SARL (no further detail)
- Activity
- Wholesale (intercompany trade) of pharmaceutical goods (46.46Z)
- Sector
- Wholesale trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 19 Sep 2000
- Share capital
- 8,000.00 EUR
- Registered with the trade register
- 30 Oct 2000
- Financial year end
- 31/12
- Establishments
- 3
Directors
- DAVID WRIGHT 61 years old, 12/1964 Gerant
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- HERA MANCO 1 via DAVID WRIGHT
- HERA MANCO 2 via DAVID WRIGHT
- HERA MANCO 3 via DAVID WRIGHT
Other companies at the same address
23 other company head offices are registered at this address.
Establishments
-
43343217600017 75020 PARIS 20
-
43343217600025 75003 PARIS 3
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low · computed on the financial year ended 31 Dec 2018
- Equity to assets (100.0 %)
- 30.0 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity
- data missing, component not taken into account
- Debt (0.0 %)
- 15.0 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
60 / 100 C
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 0.0 out of 20
- Age (26.2 years)
- 20.0 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2018 | 0 € | — | -22,588 € | 175,412 € |
| 31 Dec 2017 | 0 € | — | -1,473 € | -1,473 € |
| 31 Dec 2016 | 0 € | — | -426 € | -426 € |
| 31 Dec 2015 | 0 € | first year on record | -490 € | -549 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Striking off 4 Jan 2022
- Court :
- Greffe du Tribunal de Commerce de Nanterre
BODACC B n 20220002, annonce n 3132 · Proof of publication (PDF)
-
Amendment 9 Dec 2021
- Court :
- Greffe du Tribunal de Commerce de Nanterre
- Amendment :
- transmission universelle du patrimoine.
BODACC B n 20210239, annonce n 4193 · Proof of publication (PDF)
-
Filing of accounts 4 Jun 2019
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE NANTERRE
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2018
BODACC C n 20190106, annonce n 10850 · Proof of publication (PDF)
Change history
- officer_appointed (empty) → Gerant 9 Oct 2026
- registered_address (empty) → 200 Avenue de Paris 92320 Châtillon 1 Oct 2026
- capital (empty) → 8000.00 1 Oct 2026
Frequently asked questions about HRA PHARMA DEVELOPMENT
- What is the SIREN number of HRA PHARMA DEVELOPMENT?
- The SIREN number of HRA PHARMA DEVELOPMENT is 433432176. Its intra-community VAT number is FR94433432176.
- Where is the head office of HRA PHARMA DEVELOPMENT?
- Head office address: 200 AV DE PARIS, 92320 CHATILLON.
- When was HRA PHARMA DEVELOPMENT founded?
- HRA PHARMA DEVELOPMENT was founded on 19 Sep 2000. It ceased trading on 31 Dec 2021.
- What does HRA PHARMA DEVELOPMENT do?
- Its declared main activity is: Wholesale (intercompany trade) of pharmaceutical goods (NAF code 46.46Z).
- Who runs HRA PHARMA DEVELOPMENT?
- The officer listed in the register is DAVID WRIGHT (Gerant).
- What is the revenue of HRA PHARMA DEVELOPMENT?
- The latest published revenue is 0 €, for the 2018 financial year.
- Is HRA PHARMA DEVELOPMENT subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.